Abstracts Archive - Page 2060 of 2607 - ACR Meeting Abstracts

Abstract Number: 2624 • 2014 ACR/ARHP Annual Meeting
Impact of Provider Specialty on the Diagnosis and Management of Systemic Lupus Erythematosus in the American Indian/Alaska Native Population
John McDougall Jr.¹, Charles G. Helmick², S. Sam Lim³, Caroline Gordon⁴ and Elizabeth Ferucci⁵, ¹Department of Internal Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, ²National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, ³Emory University School of Medicine, Division of Rheumatology, Atlanta, GA, ⁴Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom, ⁵Alaska Native Medical Center, Anchorage, AK
Background/Purpose Systemic lupus erythematosus (SLE) is a complex disease that is traditionally diagnosed and managed by specialists, typically rheumatologists. Higher SLE prevalence in racial/ethnic minorities…
Abstract Number: 2623 • 2014 ACR/ARHP Annual Meeting
Treatment Patterns and Resource Utilization of Systemic Lupus Erythematosus Patients Newly Initiating Standard of Care: United States Commercial and Medicare Supplemental Claims Analysis
Shonda A Foster¹, Emily Durden², Brett Maiese², Sarah Al Sawah¹ and Kathleen Solotkin¹, ¹Eli Lilly and Company, Indianapolis, IN, ²Truven Health Analytics, Bethesda, MD
Background/Purpose: Currently, there is not a standard treatment algorithm for the management of Systemic Lupus Erythematosus (SLE); however, there are medications that may be considered…
Abstract Number: 2622 • 2014 ACR/ARHP Annual Meeting
Systemic LUPUS Erythematosus in Spanish Males
Anne Riveros-Frutos¹, Irma Casas², Iñigo Rúa-Figueroa³, José Maria Pego-Reigosa⁴, M. Jesús García de Yebenes⁵, Alejandro Olivé⁶, Jose Rosas⁷, Paloma Vela⁸, Monica Ibanez Barcelo⁹, Vicente Torrente¹⁰, Ivan Castellvi¹¹, Javier Narváez¹², Mireia Moreno¹³, R. Blanco Alonso¹⁴, Víctor Martínez Taboada¹⁵, Jaime Calvo-Alen¹⁶, Mª Angeles Aguirre¹⁷, Mercedes Freire¹⁸, Enrique Raya¹⁹, Celia Erausquin²⁰, Esther Uriarte²¹, Elvira Díez Álvarez²², Tomás Vázquez Rodríguez²³, Antonio Fernández Nebro²⁴, Eva Tomero²⁵, Paloma García de la Peña²⁶, Ana Sánchez Atrio²⁷, Monica Fernández de Castro²⁸, Antonio Zea²⁹, Patricia Richi³⁰, Francisco Lopez Longo³¹, María Galindo-Izquierdo³², Patricia Carreira³³, Gema Bonilla³⁴, Carlos Marras Fernández Cid³⁵, Maria Loreto Horcada³⁶, Carlos Montilla³⁷, Blanca Hernández-Cruz³⁸, José Marenco de la Fuente³⁹, Marian Gantes⁴⁰, Olaia Fernández Berrizbeitia⁴¹, Juan J. Alegre⁴², Ángela Pecondón Español⁴³, Manuel Rodríguez-Gómez⁴⁴, Victor Quevedo⁴⁵, José Hernández Beiraín⁴⁶ and Lucía Silva Fernández⁴⁷, ¹Rheumatology, Hospital Universitario Germans Trias i Pujol, Badalona, Spain, ²Preventive Medicine, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain, ³Rheumatology, Hospital Doctor Negrin, Las Palmas de Gran Canaria, Spain, ⁴Rheumatology, Hospital Meixoeiro, Vigo, Spain, ⁵Rheumatology, Research Unit of the SER, Madrid, Spain, ⁶Rheumatology, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain, ⁷Rheumatology, Hospital Marina Baixa. Villajoyosa, Villajoyosa, Spain, ⁸Rheumatology, Hospital General de Alicante. Spain, Alicante, Spain, ⁹H. Son Llatzer, Palma de Mallorca, Spain, ¹⁰Rheumatology, Hospital Moisès Broggi, Barcelona, Spain, ¹¹Unitat de Reumatologia., Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, ¹²Rheumatology, Hospital Universitario de Bellvitge. Barcelona. Spain, Barcelona, Spain, ¹³Rheumatology, Hospital Parc Taulí, Sabadell, Spain, ¹⁴Rheumatology, Hospital Universitario Marques de Valdecilla, Santander, Spain, ¹⁵Rheumatology, Marqués de Valdecilla, Santander, Spain, ¹⁶Rheumatology, Hospital de Sierrallana. Torrelavega. Spain, Torrelavega, Spain, ¹⁷Rheumatology, IMIBIC-Reina Sofia Hospital, Cordoba, Spain, ¹⁸Rheumatology, Hospital Universitario Juan Canalejo, La Coruña, Spain, ¹⁹Rheumatology, University Hospital San Cecilio, Granada, Spain, ²⁰Rheumatology, Hospital Dr, Negrín, Las Palmas Gran Canarias, Spain, ²¹Rheumatology, Hospital de Donosti, San Sebastian, Spain, ²²Rheumatology, Hospital de León. Spain, León, Spain, ²³Rheumatology, Hospital Lucus Augusti, Lugo, Spain, ²⁴Rheumatology, Hospital Carlos Haya. Malaga, Malaga, Spain, ²⁵Rheumatology, Hospital Universitario de La Princesa. IIS La Princesa, Madrid, Spain, ²⁶Rheumatology, Hospital Norte Sanchinarro, Madrid, Spain, ²⁷Hospital Príncipe de Asturias, Immune System Diseases/Rheumatology department, Alcalá de Henares, Madrid, Spain, ²⁸Hospital Puerta del Hierro, Madrid, Spain, ²⁹Rheumatology, Hospital Universitario Ramon y Cajal, Madrid, Spain, ³⁰Hospital Infanta Sofía, Madrid, Spain, ³¹Rheumatology, Hospital Gregorio Marañón, Madrid, Spain, ³²Rheumatology, Hospital 12 de octubre, Madrid, Spain, ³³Rheumatology, Hospital Universitario 12 de Octubre, Madrid, Spain, ³⁴Rheumatology, Hospital La Paz, Madrid, Spain, ³⁵Hospital Virgen de la Arrixaca, Murcia, Spain, ³⁶Rheumatology, Complejo Hospitalario de Navarra, Pamplona, Spain, ³⁷Rheumatology, Hospital Clínico Universitario de Salamanca, Salamanca, Spain, ³⁸Rheumatology, University Hospital Virgen Macarena, Sevilla, Spain, ³⁹Rheumatology, Hospital de Valme, Sevilla, Spain, ⁴⁰Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain, ⁴¹Rheumatology, Hospital de Basurto, Bilbao, Spain, ⁴²Rheumatology, Hospital Universitario Dr Peset, Valencia, Spain, ⁴³Rheumatology, Hospital Miguel Servet, Zaragoza, Spain, ⁴⁴Rheumatology, Complejo Hospitalario Universitario de Ourense, Ourense, Spain, ⁴⁵Rheumatology, Hospital de Monforte, Lugo, Spain, ⁴⁶Rheumatology, Hospital Insular de Gran Canaria, Las palmas Gran Canarias, Spain, ⁴⁷Rheumatology, Hospital Universitario de Guadalajara, Guadalajara, Spain

Background/Purpose: To describe the demographic, clinical and immunological manifestations in male patients with Systemic Lupus Erythematosus(SLE) Methods: Patients diagnosed of SLE that were in the…
Abstract Number: 2621 • 2014 ACR/ARHP Annual Meeting
Health-Related Quality of Life in Patients with Systemic Lupus Erythematosus
Jin-Shei Lai¹, Karen Kaiser¹, Jennifer Beaumont¹, Sally Jensen¹, Amy H Kao², David Van Brunt³ and Shih-Yin Chen², ¹Northwestern University, Chicago, IL, ²Biogen Idec, Cambridge, MA, ³Formerly of Biogen Idec, Cambridge, MA
Background/Purpose: Systemic lupus erythematosus (SLE) is a multi-organ chronic autoimmune disease that can negatively affect patients' health-related quality of life (HRQOL). This cross-sectional study collected…
Abstract Number: 2603 • 2014 ACR/ARHP Annual Meeting
Short-Term Non-Steroidal Anti-Inflammatory Drug (NSAID) Use Induces Subclinical-Kidney-Injury in Spondyloarthritis Patients: Urinary Biomarker Study
Anuj Shukla¹, Mohit kumar Rai¹, Narayan Prasad² and Vikas Agarwal¹, ¹Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India, ²Nephrology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
Background/Purpose NSAIDs are the first-line therapy for spondyloarthritis (SpA) patients and are associated with the risk of kidney injury. Long-term NSAID use is known to…
Abstract Number: 2604 • 2014 ACR/ARHP Annual Meeting
Ankylosing Spondylitis and Non- Radiographic Axial Spondyloarthritis : the Same Syndrome or Different Diseases? Analysis from Esperanza Cohort
Azucena Hernández-Sanz¹, Victoria Navarro-Compán², Cristina Fernández-Carballido³, Carlos Montilla-Morales⁴, Juan Mulero⁵ and Eugenio De Miguel⁶, ¹H. Virgen de la Salud, Toledo, Spain, ²Rheumatology, University Hospital La Paz, Madrid, Spain, ³Rheumatology, University General Hospital Elda, Elda (Alicante), Spain, ⁴H. de Salamanca, Salamanca, Spain, ⁵Rheumatology, University Hospital Puerta de Hierro, Majadahonda (Madrid), Spain, ⁶Department of Rheumatology, Hospital Universitario La Paz, Madrid, Spain
Background/Purpose New ASAS criteria for axial spondyloarthritis (axSpA) have two entrances: the imaging and clinical arm (presence of HLA B27). The imaging arm allows classifying patients…
Abstract Number: 2602 • 2014 ACR/ARHP Annual Meeting
Prevalence of Subclinical Atherosclerosis in Patients with Spondyloarthritis without Clinically Evident Cardiovascular Disease Using Carotid Intima-Media Thickness
Elena Alonso Blanco-Morales¹, Carmen Bejerano², Carlos Fernandez-Lopez³, Natividad Oreiro⁴, Javier De Toro⁴, Francisco J. Blanco Garcia³ and Jose A Pinto-Tasende³, ¹INIBIC. Complejo Hospitalario Universitario A Coruña, A Coruña, Spain, ²INIBIC, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain, ³Rheumatology Department, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain, ⁴Rheumatology Department, A Coruña, Spain
Background/Purpose AS and PsA patients without clinically evident cardiovascular disease have a high prevalence of subclinical cardiovascular disease in form of increased carotid intima-media thickness…
Abstract Number: 2601 • 2014 ACR/ARHP Annual Meeting
Serum Biomarkers Associated with Changes in ASDAS and MRI Following Treatment of Ankylosing Spondylitis with Golimumab
Robert D. Inman¹, Xenofon Baraliakos², Kay-Geert A. Hermann³, Jürgen Braun⁴, Atul A. Deodhar⁵, Désirée van der Heijde⁶, Stephen Xu⁷ and Benjamin Hsu⁷, ¹Immunlogy and Institute of Medical Science, University of Toronto and Toronto Western Hospital, Toronto, ON, Canada, ²Rheumatology, Rheumazentrum Ruhrgebiet, Herne, Germany, ³Radiology, Charité Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany, ⁴Rheumazentrum Ruhrgebiet, Herne, Germany, ⁵Oregon Health and Sciences University, Portland, OR, ⁶Leiden University Medical Center, Leiden, Netherlands, ⁷Janssen Research & Development, LLC., Spring House, PA
Background/Purpose Serum biomarkers that can predict subsequent clinical or imaging outcomes would aid decision-making in the management of ankylosing spondylitis (AS). Using data from the…
Abstract Number: 2600 • 2014 ACR/ARHP Annual Meeting
Gender-Attributable Differences in Outcome of Ankylosing Spondylitis: Long-Term Results from the Outcome in Ankylosing Spondylitis International Study
Casper Webers¹, Ivette Essers^1,2, Sofia Ramiro^3,4, Carmen Stolwijk^1,2, Robert Landewé⁵, Désirée van der Heijde⁶, Filip van Den Bosch⁷, Maxime Dougados^8,9 and Astrid van Tubergen^1,10, ¹Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, ²School for Public Health and Primary Care (CAPHRI), Maastricht University, Maastricht, Netherlands, ³Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center/University of Amsterdam, Amsterdam, Netherlands, ⁴Rheumatology, Hospital Garcia de Orta, Almada, Portugal, ⁵Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, ⁶Leiden University Medical Center, Leiden, Netherlands, ⁷Rheumatology, Department of Rheumatology Ghent University Hospital, Ghent, Belgium, ⁸Paris-Descartes University, Paris, France, ⁹Rheumatology, Hopital Cochin, Descartes University, Paris, France, ¹⁰Care and Public Health Research Institute, Maastricht University, Maastricht, Netherlands
Background/Purpose: In ankylosing spondylitis (AS), gender-attributable differences have been reported with respect to clinical and radiographic outcome. However, longitudinal studies exploring gender-attributable differences in the…
Abstract Number: 2599 • 2014 ACR/ARHP Annual Meeting
Do Patients Diagnosed As Axial Spondyloarthritis (AxSpA) Who Have Primary Inefficacy to Anti-TNF Really Have AxSpA? a Five-Year Follow-up Study of 27 Patients with Primary Inefficacy to Anti-TNF
Sandra Kossi¹, Sabrina Dadoun², Bruno Fautrel², Maxime Dougados³ and Laure Gossec⁴, ¹75, Hopital La Pitie Salpetrière, Paris, France, ²Rheumatology, UPMC GRC08, Paris 06 University, Pitié Salpétrière Hospital, Paris, France, ³INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France., Paris, France, ⁴Sorbonne Universités, UPMC Univ Paris 06, GRC-08, Institut Pierre Louis d’Epidémiologie et de Santé Publique, paris, France
Background/Purpose The diagnosis of AxSpA is not easy and there are cases of overlap with fibromyalgia for example. Anti-TNF have been shown to have great…
Abstract Number: 2598 • 2014 ACR/ARHP Annual Meeting
Disease Characteristics Associated with the Presence of Dactylitis in Patients with EARLY Spondyloarthritis: Results from Esperenza Cohort
Maria Isabel Tévar Sánchez¹, Victoria Navarro-Compán², Raquel Almodóvar González³, Maria Pilar Fernández Dapica⁴, Pedro Zarco⁵ and Eugenio De Miguel⁶, ¹Hospital Vega Baja, Orihuela, Alicante, Spain, ²Rheumatology, University Hospital La Paz, Madrid, Spain, ³Rheumatology Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain, ⁴University Hospital 12 de Octubre, Madrid, Spain, ⁵Rheumatology Department, Fundación Hospital Alcorcon, Alcorcon, Madrid, Spain, ⁶Department of Rheumatology, Hospital Universitario La Paz, Madrid, Spain
Background/Purpose: Dactylitis is a typical manifestation in patients with SpA. Despite dactylitis has traditionally been related to the coexistence of psoriasis and peripheral arthritis, it…
Abstract Number: 2597 • 2014 ACR/ARHP Annual Meeting
Impact of Repeating Imaging of the Sacro-Iliac Joints over One Year on the Classification According the ASAS Axial Spa Criteria of Patients
Pauline Bakker¹, Manouk de Hooge¹, Rosaline van den Berg², Floris van Gaalen², Monique Reijnierse¹, T.W.J. Huizinga¹ and Désirée van der Heijde³, ¹Leiden University Medical Center, Leiden, Netherlands, ²Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ³Rheumatology, Diakonhjemmet Hospital, Oslo, Norway
Background/Purpose: It is known that in axial spondyloarthritis (axSpA) inflammatory lesions on MRI of the SI joints (MRI-SI) can change over time. The usefulness of…
Abstract Number: 2596 • 2014 ACR/ARHP Annual Meeting
Similarities and Differences Between Axial and Peripheral Predominant Forms in patients with Early Spondyloarthritis (SpA): Results from the Esperanza Cohort
Pilar del Río-Martínez¹, Victoria Navarro-Compán², Concepción Castillo-Gallego³, M. Carmen Castro⁴, Eduardo Collantes-Estévez⁴ and Eugenio De Miguel³, ¹Rheumatology,, Rheumatologist, Zaragoza, Spain, ²Rheumatology, Rheumatologist, Madrid, Spain, ³Rheumatology,, Rheumatologist, Madrid, Spain, ⁴Rheumatology, Rheumatologist, Córdoba, Spain

Background/Purpose: Based on the predominant manifestation of the disease, the ASAS classification criteria for spondyloarthritis (SpA) distinguish two clinical forms: •Axial SpA, including non-radiographic SpA…
Abstract Number: 2595 • 2014 ACR/ARHP Annual Meeting
Using Iphone Compass Application for the Assessment of Cervical Rotation in Patients with Ankylosing Spondylitis
Gokce Kenar, Berrin Zengin, Handan Yarkan, Pinar Cetin, Ismail Sari, Fatos Onen, Merih Birlik and Nurullah Akkoc, Rheumatology, Dokuz Eylul University School of Medicine, Izmir, Turkey
Background/Purpose Cervical rotation reflects restriction of mobility in axial disease in ankylosing spondylitis (AS) and it can be assessed in several approaches based on the…
Abstract Number: 2594 • 2014 ACR/ARHP Annual Meeting
Differences in Localization and Activity of the Entheseal Involvement Between Non-Radiographic and Radiographic Axial Spondyloarthritis By the Ultrasound Assessment
Marketa Fojtikova¹, Karel Pavelka¹, Sarka Forejtova² and Jindra Gatterova³, ¹Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic, ²Rheumatology, Institute of Rheumatology, Prague, Czech Republic, ³Institute of rheumatology, Prague 2, Czech Republic
Background/Purpose Inflammatory involvement of peripheral enthesis belongs to an important sign of spondyloarthritis (SpA). It may occur in patients with long-term as well as newly…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].